Table of Content

1. Introduction


2. Research & Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Global Blood Glucose (SMBG) Market and Users

5.1 Blood Glucose Device Market (Type1 + Type 2) Diabetes

5.1.1 Type 1 Diabetes
5.1.2 Type 2 Diabetes

5.2 Test Strips Market and Forecast

5.2.1 Type 1 Diabetes
5.2.2 Type 2 Diabetes

5.3 Lancet Market and Forecast

5.3.1 Type 1 Diabetes
5.3.2 Type 2 Diabetes

5.4 Meter Market and Forecast

5.4.1 Type 1 Diabetes
5.4.2 Type 2 Diabetes

5.5 Global Diabetes Population (Type1 + Type 2)

5.5.1 Type 1 Diabetes Population
5.5.2 Type 2 Diabetes Population

5.6 Blood Glucose (SMBG) Device Users (Type1 + Type 2)

5.6.1 Type 1 Diabetes Blood Glucose (SMBG) Device Users
5.6.2 Type 2 Diabetes Blood Glucose (SMBG) Device Users


6. Share Analysis – Blood Glucose Device Market, Diabetes Population, SMBG User

6.1 SMBG Market Share

6.1.1 Total SMBG Market Share

6.1.1.1 Type 1
6.1.1.2 Type 2

6.1.2 Test Strips

6.1.2.1 Type 1
6.1.2.2 Type 2

6.1.3 Lancet

6.1.3.1 Type 1
6.1.3.2 Type 2

6.1.4 Blood Glucose Meter

6.1.4.1 Type 1
6.1.4.2 Type 2

6.1.5 Diabetes Population Share

6.1.5.1 Type 1 Diabetes
6.1.5.2 Type 2 Diabetes

6.1.6 Blood Glucose Device User Share & Forecast

6.1.6.1 Type 1 Diabetes
6.1.6.2 Type 2 Diabetes


7. United States

7.1 United States Diabetes Population

7.1.1 Type 1 Diabetes
7.1.2 Type 2 Diabetes

7.2 Blood Glucose Device (SMBG) Market

7.2.1 Test Strips (Diabetes) Market

7.2.1.1 Type 1
7.2.1.2 Type 2

7.2.2 Lancet (Diabetes) Market

7.2.2.1 Type 1
7.2.2.2 Type 2

7.2.3 Glucose Meter (Diabetes) Market

7.2.3.1 Type 1
7.2.3.2 Type 2

7.3 Blood Glucose (SMBG) (Diabetes) Users

7.3.1 Type 1
7.3.2 Type 2

7.4 Reimbursement of Blood Glucose Devices in United States


8. United Kingdom

8.1 United States Diabetes Population

8.1.1 Type 1 Diabetes
8.1.2 Type 2 Diabetes

8.2 Blood Glucose Device (SMBG) Market

8.2.1 Test Strips (Diabetes) Market

8.2.1.1 Type 1
8.2.1.2 Type 2

8.2.2 Lancet (Diabetes) Market

8.2.2.1 Type 1
8.2.2.2 Type 2

8.2.3 Glucose Meter (Diabetes) Market

8.2.3.1 Type 1
8.2.3.2 Type 2

8.3 Blood Glucose (SMBG) (Diabetes) Users

8.3.1 Type 1
8.3.2 Type 2

8.4 Reimbursement of Blood Glucose Devices in United States


9. Germany

9.1 Germany Diabetes Population

9.1.1 Type 1 Diabetes
9.1.2 Type 2 Diabetes

9.2 Blood Glucose Device (SMBG) Market

9.2.1 Test Strips (Diabetes) Market

9.2.1.1 Type 1
9.2.1.2 Type 2

9.2.2 Lancet (Diabetes) Market

9.2.2.1 Type 1
9.2.2.2 Type 2

9.2.3 Glucose Meter (Diabetes) Market

9.2.3.1 Type 1
9.2.3.2 Type 2

9.3 Blood Glucose (SMBG) (Diabetes) Users

9.3.1 Type 1
9.3.2 Type 2

9.4 Reimbursement of Blood Glucose Devices in United States


10. Spain

10.1 Spain Diabetes Population

10.1.1 Type 1 Diabetes
10.1.2 Type 2 Diabetes

10.2 Blood Glucose Device (SMBG) Market

10.2.1 Test Strips (Diabetes) Market

10.2.1.1 Type 1
10.2.1.2 Type 2

10.2.2 Lancet (Diabetes) Market

10.2.2.1 Type 1
10.2.2.2 Type 2

10.2.3 Glucose Meter (Diabetes) Market

10.2.3.1 Type 1
10.2.3.2 Type 2

10.3 Blood Glucose (SMBG) (Diabetes) Users

10.3.1 Type 1
10.3.2 Type 2

10.4 Reimbursement of Blood Glucose Devices in United States




11. Italy

11.1 Italy Diabetes Population

11.1.1 Type 1 Diabetes
11.1.2 Type 2 Diabetes

11.2 Blood Glucose Device (SMBG) Market

11.2.1 Test Strips (Diabetes) Market

11.2.1.1 Type 1
11.2.1.2 Type 2

11.2.2 Lancet (Diabetes) Market

11.2.2.1 Type 1
11.2.2.2 Type 2

11.2.3 Glucose Meter (Diabetes) Market

11.2.3.1 Type 1
11.2.3.2 Type 2

11.3 Blood Glucose (SMBG) (Diabetes) Users

11.3.1 Type 1
11.3.2 Type 2

11.4 Reimbursement of Blood Glucose Devices in United States


12. Netherlands

12.1 Netherlands Diabetes Population

12.1.1 Type 1 Diabetes
12.1.2 Type 2 Diabetes

12.2 Blood Glucose Device (SMBG) Market

12.2.1 Test Strips (Diabetes) Market

12.2.1.1 Type 1
12.2.1.2 Type 2

12.2.2 Lancet (Diabetes) Market

12.2.2.1 Type 1
12.2.2.2 Type 2

12.2.3 Glucose Meter (Diabetes) Market
12.2.3.1 Type 1
12.2.3.2 Type 2

12.3 Blood Glucose (SMBG) (Diabetes) Users

12.3.1 Type 1
12.3.2 Type 2

12.4 Reimbursement of Blood Glucose Devices in United States


13. Norway

13.1 Norway Diabetes Population

13.1.1 Type 1 Diabetes
13.1.2 Type 2 Diabetes

13.2 Blood Glucose Device (SMBG) Market

13.2.1 Test Strips (Diabetes) Market

13.2.1.1 Type 1
13.2.1.2 Type 2

13.2.2 Lancet (Diabetes) Market

13.2.2.1 Type 1
13.2.2.2 Type 2

13.2.3 Glucose Meter (Diabetes) Market

13.2.3.1 Type 1
13.2.3.2 Type 2

13.3 Blood Glucose (SMBG) (Diabetes) Users

13.3.1 Type 1
13.3.2 Type 2

13.4 Reimbursement of Blood Glucose Devices in United States

14. Sweden

14.1 Sweden Diabetes Population

14.1.1 Type 1 Diabetes
14.1.2 Type 2 Diabetes

14.2 Blood Glucose Device (SMBG) Market

14.2.1 Test Strips (Diabetes) Market

14.2.1.1 Type 1
14.2.1.2 Type 2

14.2.2 Lancet (Diabetes) Market

14.2.2.1 Type 1
14.2.2.2 Type 2

14.2.3 Glucose Meter (Diabetes) Market

14.2.3.1 Type 1
14.2.3.2 Type 2

14.3 Blood Glucose (SMBG) (Diabetes) Users

14.3.1 Type 1
14.3.2 Type 2

14.4 Reimbursement of Blood Glucose Devices in United States

15. Switzerland

15.1 Switzerland Diabetes Population

15.1.1 Type 1 Diabetes
15.1.2 Type 2 Diabetes

15.2 Blood Glucose Device (SMBG) Market

15.2.1 Test Strips (Diabetes) Market

15.2.1.1 Type 1
15.2.1.2 Type 2

15.2.2 Lancet (Diabetes) Market

15.2.2.1 Type 1
15.2.2.2 Type 2

15.2.3 Glucose Meter (Diabetes) Market

15.2.3.1 Type 1
15.2.3.2 Type 2

15.3 Blood Glucose (SMBG) (Diabetes) Users

15.3.1 Type 1
15.3.2 Type 2

15.4 Reimbursement of Blood Glucose Devices in United States

16. Australia

16.1 Australia Diabetes Population

16.1.1 Type 1 Diabetes
16.1.2 Type 2 Diabetes

16.2 Blood Glucose Device (SMBG) Market

16.2.1 Test Strips (Diabetes) Market

16.2.1.1 Type 1
16.2.1.2 Type 2

16.2.2 Lancet (Diabetes) Market

16.2.2.1 Type 1
16.2.2.2 Type 2

16.2.3 Glucose Meter (Diabetes) Market

16.2.3.1 Type 1
16.2.3.2 Type 2

16.3 Blood Glucose (SMBG) (Diabetes) Users

16.3.1 Type 1
16.3.2 Type 2

16.4 Reimbursement of Blood Glucose Devices in United States

17. Kuwait

17.1 Kuwait Diabetes Population

17.1.1 Type 1 Diabetes
17.1.2 Type 2 Diabetes

17.2 Blood Glucose Device (SMBG) Market

17.2.1 Test Strips (Diabetes) Market

17.2.1.1 Type 1
17.2.1.2 Type 2

17.2.2 Lancet (Diabetes) Market

17.2.2.1 Type 1
17.2.2.2 Type 2

17.2.3 Glucose Meter (Diabetes) Market

17.2.3.1 Type 1
17.2.3.2 Type 2

17.3 Blood Glucose (SMBG) (Diabetes) Users

17.3.1 Type 1
17.3.2 Type 2

17.4 Reimbursement of Blood Glucose Devices in United States

18. Brazil

18.1 Brazil Diabetes Population

18.1.1 Type 1 Diabetes
18.1.2 Type 2 Diabetes

18.2 Blood Glucose Device (SMBG) Market

18.2.1 Test Strips (Diabetes) Market

18.2.1.1 Type 1
18.2.1.2 Type 2

18.2.2 Lancet (Diabetes) Market

18.2.2.1 Type 1
18.2.2.2 Type 2

18.2.3 Glucose Meter (Diabetes) Market

18.2.3.1 Type 1
18.2.3.2 Type 2

18.3 Blood Glucose (SMBG) (Diabetes) Users

18.3.1 Type 1
18.3.2 Type 2

18.4 Reimbursement of Blood Glucose Devices in United States

19. Russia

19.1 Russia Diabetes Population

19.1.1 Type 1 Diabetes
19.1.2 Type 2 Diabetes

19.2 Blood Glucose Device (SMBG) Market

19.2.1 Test Strips (Diabetes) Market

19.2.1.1 Type 1
19.2.1.2 Type 2

19.2.2 Lancet (Diabetes) Market

19.2.2.1 Type 1
19.2.2.2 Type 2

19.2.3 Glucose Meter (Diabetes) Market

19.2.3.1 Type 1
19.2.3.2 Type 2

19.3 Blood Glucose (SMBG) (Diabetes) Users

19.3.1 Type 1
19.3.2 Type 2

19.4 Reimbursement of Blood Glucose Devices in United States


20. India

20.1 India Diabetes Population

20.1.1 Type 1 Diabetes
20.1.2 Type 2 Diabetes

20.2 Blood Glucose Device (SMBG) Market

20.2.1 Test Strips (Diabetes) Market

20.2.1.1 Type 1
20.2.1.2 Type 2

20.2.2 Lancet (Diabetes) Market

20.2.2.1 Type 1
20.2.2.2 Type 2

20.2.3 Glucose Meter (Diabetes) Market

20.2.3.1 Type 1
20.2.3.2 Type 2

20.3 Blood Glucose (SMBG) (Diabetes) Users

20.3.1 Type 1
20.3.2 Type 2

20.4 Reimbursement of Blood Glucose Devices in United States

21. China

21.1 China Diabetes Population

21.1.1 Type 1 Diabetes
21.1.2 Type 2 Diabetes

21.2 Blood Glucose Device (SMBG) Market

21.2.1 Test Strips (Diabetes) Market

21.2.1.1 Type 1
21.2.1.2 Type 2

21.2.2 Lancet (Diabetes) Market

21.2.2.1 Type 1
21.2.2.2 Type 2

21.2.3 Glucose Meter (Diabetes) Market

21.2.3.1 Type 1
21.2.3.2 Type 2

21.3 Blood Glucose (SMBG) (Diabetes) Users

21.3.1 Type 1
21.3.2 Type 2

21.4 Reimbursement of Blood Glucose Devices in United States

22. South Africa

22.1 South Africa Diabetes Population

22.1.1 Type 1 Diabetes
22.1.2 Type 2 Diabetes

22.2 Blood Glucose Device (SMBG) Market

22.2.1 Test Strips (Diabetes) Market

22.2.1.1 Type 1
22.2.1.2 Type 2

22.2.2 Lancet (Diabetes) Market

22.2.2.1 Type 1
22.2.2.2 Type 2

22.2.3 Glucose Meter (Diabetes) Market

22.2.3.1 Type 1
22.2.3.2 Type 2

22.3 Blood Glucose (SMBG) (Diabetes) Users

22.3.1 Type 1
22.3.2 Type 2

22.4 Reimbursement of Blood Glucose Devices in United States

23. Saudi Arabia

23.1 Saudi Arabia Diabetes Population

23.1.1 Type 1 Diabetes
23.1.2 Type 2 Diabetes

23.2 Blood Glucose Device (SMBG) Market

23.2.1 Test Strips (Diabetes) Market

23.2.1.1 Type 1
23.2.1.2 Type 2

23.2.2 Lancet (Diabetes) Market

23.2.2.1 Type 1
23.2.2.2 Type 2

23.2.3 Glucose Meter (Diabetes) Market

23.2.3.1 Type 1
23.2.3.2 Type 2

23.3 Blood Glucose (SMBG) (Diabetes) Users

23.3.1 Type 1
23.3.2 Type 2

23.4 Reimbursement of Blood Glucose Devices in United States

24. Company Analysis

24.1 Roche Diagnostic

24.1.1 Overview
24.1.2 Recent Developments
24.1.3 Revenue

24.2 Abbott Laboratories

24.2.1 Overview
24.2.2 Recent Developments
24.2.3 Revenue

24.3 Dexcom, Inc.

24.3.1 Overview
24.3.2 Recent Developments
24.3.3 Revenue

24.4 Medtronic

24.4.1 Overview
24.4.2 Recent Developments
24.4.3 Revenue

24.5 B. Braun Melsungen AG

24.5.1 Overview
24.5.2 Recent Developments
24.5.3 Revenue

24.6 DarioHealth Corp

24.6.1 Overview
24.6.2 Recent Developments
24.6.3 Revenue



List of Figures

Figure-01: Global – Blood Glucose (SMBG) Device Market (Million US$), 2017 – 2021
Figure-02: Global – Forecast for Blood Glucose (SMBG) Device Market (Million US$), 2022 – 2027
Figure-03: Global – Blood Glucose Device Type 1 Market (Million US$), 2017 – 2021
Figure-04: Global – Forecast for Blood Glucose Device Type 1 Market (Million US$), 2022 – 2027
Figure-05: Global – Blood Glucose Device Type 2 Market (Million US$), 2017 – 2021
Figure-06: Global – Forecast for Blood Glucose Device Type 2 Market (Million US$), 2022 – 2027
Figure-07: Global – Test Strips Type 1 Market (Million US$), 2017 – 2021
Figure-08: Global – Forecast for Test Strips Type 1 Market (Million US$), 2022 – 2027
Figure-09: Global – Test Strips Type 2 Market (Million US$), 2017 – 2021
Figure-10: Global – Forecast for Test Strips Type 2 Market (Million US$), 2022 – 2027
Figure-11: Global – Lancet Type 1 Market (Million US$), 2017 – 2021
Figure-12: Global – Forecast for Lancet Type 1 Market (Million US$), 2022 – 2027
Figure-13: Global – Lancet Type 2 Market (Million US$), 2017 – 2021
Figure-14: Global – Forecast for Lancet Type 2 Market (Million US$), 2022 – 2027
Figure-15: Global – Glucometer Type 1 Market (Million US$), 2017 – 2021
Figure-16: Global – Forecast for Glucometer Type 1 Market (Million US$), 2022 – 2027
Figure-17: Global – Glucometer Type 2 Market (Million US$), 2017 – 2021
Figure-18: Global – Forecast for Glucometer Type 2 Market (Million US$), 2022 – 2027
Figure-19: Global – Diabetes Type 1 Population Volume (Thousand), 2017 – 2021
Figure-20: Global – Forecast for Diabetes Type 1 Population Volume (Thousand), 2022 – 2027
Figure-21: Global – Diabetes Type 2 Population Volume (Thousand), 2017 – 2021
Figure-22: Global – Forecast for Diabetes Type 2 Population Volume (Thousand), 2022 – 2027
Figure-23: Global – Blood Glucose Device Type 1 Users Volume (Thousand), 2017 – 2021
Figure-24: Global – Forecast for Blood Glucose Device Type 1 Users Volume (Thousand), 2022 – 2027
Figure-25: Global – Blood Glucose Device Type 2 Users Volume (Thousand), 2017 – 2021
Figure-26: Global – Forecast for Blood Glucose Device Type 2 Users Volume (Thousand), 2022 – 2027
Figure-27: United States – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-28: United States – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-29: United States – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-30: United States – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-31: United States – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-32: United States – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-33: United States – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-34: United States – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-35: United States – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-36: United States – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-37: United States – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-38: United States – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-39: United States – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-40: United States – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-41: United States – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-42: United States – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-43: United States – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-44: United States – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-45: United States – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-46: United States – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-47: United Kingdom – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-48: United Kingdom – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-49: United Kingdom – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-50: United Kingdom – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-51: United Kingdom – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-52: United Kingdom – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-53: United Kingdom – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-54: United Kingdom – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-55: United Kingdom – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-56: United Kingdom – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-57: United Kingdom – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-58: United Kingdom – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-59: United Kingdom – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-60: United Kingdom – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-61: United Kingdom – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-62: United Kingdom – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-63: United Kingdom – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-64: United Kingdom – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-65: United Kingdom – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-66: United Kingdom – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-67: Germany – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-68: Germany – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-69: Germany – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-70: Germany – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-71: Germany – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-72: Germany – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-73: Germany – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-74: Germany – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-75: Germany – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-76: Germany – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-77: Germany – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-78: Germany – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-79: Germany – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-80: Germany – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-81: Germany – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-82: Germany – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-83: Germany – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-84: Germany – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-85: Germany – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-86: Germany – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-87: Spain – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-88: Spain – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-89: Spain – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-90: Spain – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-91: Spain – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-92: Spain – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-93: Spain – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-94: Spain – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-95: Spain – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-96: Spain – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-97: Spain – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-98: Spain – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-99: Spain – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-100: Spain – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-101: Spain – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-102: Spain – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-103: Spain – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-104: Spain – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-105: Spain – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-106: Spain – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-107: Italy – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-108: Italy – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-109: Italy – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-110: Italy – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-111: Italy – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-112: Italy – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-113: Italy – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-114: Italy – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-115: Italy – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-116: Italy – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-117: Italy – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-118: Italy – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-119: Italy – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-120: Italy – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-121: Italy – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-122: Italy – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-123: Italy – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-124: Italy – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-125: Italy – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-126: Italy – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-127: Netherlands – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-128: Netherlands – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-129: Netherlands – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-130: Netherlands – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-131: Netherlands – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-132: Netherlands – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-133: Netherlands – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-134: Netherlands – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-135: Netherlands – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-136: Netherlands – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-137: Netherlands – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-138: Netherlands – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-139: Netherlands – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-140: Netherlands – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-141: Netherlands – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-142: Netherlands – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-143: Netherlands – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-144: Netherlands – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-145: Netherlands – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-146: Netherlands – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-147: Norway – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-148: Norway – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-149: Norway – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-150: Norway – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-151: Norway – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-152: Norway – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-153: Norway – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-154: Norway – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-155: Norway – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-156: Norway – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-157: Norway – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-158: Norway – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-159: Norway – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-160: Norway – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-161: Norway – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-162: Norway – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-163: Norway – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-164: Norway – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-165: Norway – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-166: Norway – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-167: Sweden – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-168: Sweden – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-169: Sweden – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-170: Sweden – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-171: Sweden – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-172: Sweden – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-173: Sweden – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-174: Sweden – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-175: Sweden – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-176: Sweden – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-177: Sweden – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-178: Sweden – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-179: Sweden – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-180: Sweden – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-181: Sweden – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-182: Sweden – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-183: Sweden – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-184: Sweden – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-185: Sweden – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-186: Sweden – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-187: Switzerland – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-188: Switzerland – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-189: Switzerland – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-190: Switzerland – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-191: Switzerland – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-192: Switzerland – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-193: Switzerland – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-194: Switzerland – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-195: Switzerland – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-196: Switzerland – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-197: Switzerland – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-198: Switzerland – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-199: Switzerland – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-200: Switzerland – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-201: Switzerland – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-202: Switzerland – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-203: Switzerland – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-204: Switzerland – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-205: Switzerland – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-206: Switzerland – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-207: Australia – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-208: Australia – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-209: Australia – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-210: Australia – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-211: Australia – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-212: Australia – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-213: Australia – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-214: Australia – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-215: Australia – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-216: Australia – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-217: Australia – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-218: Australia – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-219: Australia – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-220: Australia – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-221: Australia – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-222: Australia – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-223: Australia – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-224: Australia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-225: Australia – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-226: Australia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-227: Kuwait – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-228: Kuwait – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-229: Kuwait – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-230: Kuwait – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-231: Kuwait – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-232: Kuwait – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-233: Kuwait – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-234: Kuwait – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-235: Kuwait – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-236: Kuwait – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-237: Kuwait – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-238: Kuwait – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-239: Kuwait – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-240: Kuwait – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-241: Kuwait – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-242: Kuwait – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-243: Kuwait – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-244: Kuwait – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-245: Kuwait – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-246: Kuwait – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-247: Brazil – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-248: Brazil – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-249: Brazil – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-250: Brazil – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-251: Brazil – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-252: Brazil – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-253: Brazil – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-254: Brazil – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-255: Brazil – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-256: Brazil – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-257: Brazil – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-258: Brazil – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-259: Brazil – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-260: Brazil – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-261: Brazil – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-262: Brazil – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-263: Brazil – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-264: Brazil – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-265: Brazil – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-266: Brazil – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-267: Russia – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-268: Russia – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-269: Russia – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-270: Russia – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-271: Russia – Test Strips (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-272: Russia – Forecast for Test Strips (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-273: Russia – Test Strips (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-274: Russia – Forecast for Test Strips (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-275: Russia – Lancet (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-276: Russia – Forecast for Lancet (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-277: Russia – Lancet (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-278: Russia – Forecast for Lancet (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-279: Russia – Glucose Meter (Diabetes) Type 1 Market (Million US$), 2017 – 2021
Figure-280: Russia – Forecast for Glucose Meter (Diabetes) Type 1 Market (Million US$), 2022 – 2027
Figure-281: Russia – Glucose Meter (Diabetes) Type 2 Market (Million US$), 2017 – 2021
Figure-282: Russia – Forecast for Glucose Meter (Diabetes) Type 2 Market (Million US$), 2022 – 2027
Figure-283: Russia – Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2017 – 2021
Figure-284: Russia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 1 Users Volume (Thousand), 2022 – 2027
Figure-285: Russia – Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2017 – 2021
Figure-286: Russia – Forecast for Blood Glucose (SMBG) (Diabetes) Type 2 Users Volume (Thousand), 2022 – 2027
Figure-287: India – Diabetes Type 1 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-288: India – Forecast for Diabetes Type 1 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-289: India – Diabetes Type 2 Diabetes Population Volume (Thousand), 2017 – 2021
Figure-290: India – Forecast for Diabetes Type 2 Diabetes Population Volume (Thousand), 2022 – 2027
Figure-291: India – Test Strips (Diabetes) Type 1 Market (Million